A Study of Prevalence of EGFR Mutations in Participants With NSCLC

Roche logo

Roche

Status

Completed

Conditions

Non-Small Cell Lung Cancer

Study type

Observational

Funder types

Industry

Identifiers

NCT02695849
ML25269

Details and patient eligibility

About

This is a non-interventional, local, multicenter, cross-sectional study to determine the prevalence of epidermal growth factor receptor (EGFR) mutations in participants diagnosed with non-squamous non-small cell lung cancer (NSCLC).

Enrollment

69 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Informed consent form signature
  • Jordanian male and female participants greater than or equal to (>=) 18 years of age
  • Histologically confirmed NSCLC
  • Not participating in a study that involves an investigational agent within 30 days prior to enrollment

Exclusion criteria

  • Other primary malignancy
  • Fine needle aspiration samples

Trial design

69 participants in 1 patient group

NSCLC Participants
Description:
Participants with non-squamous NSCLC will be enrolled in this study.

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems